Prostate Cancer Clinical Trials in Cleveland

Showing 201-220 of 374 trials

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

NCT03182998

This randomized phase III trial studies how well decision aids work in improving knowledge in patients with prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

Prostate Cancer

Mayo Clinic103 participantsStarted Jul 2017

Anchorage, Alaska, United States • Scottsdale, Arizona, United States • Cleveland, Ohio, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005847

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known which treatment regimen is more effective in treating metastatic prostate cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of combination chemotherapy with that of chemotherapy plus biological therapy in treating patients who have progressive or metastatic prostate cancer that has not responded to hormone therapy.

Prostate Cancer

Eastern Cooperative Oncology GroupStarted Apr 2001

Denver, Colorado, United States • Atlanta, Georgia, United States • Decatur, Georgia, United States +16 more locations

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer Trials in Other Cities

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Pioneering Advances in Care and Education (PACE)

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

A Study of FT-7051 in Men With MCRPC

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

Telomere Associated Variables (TAVs) in Prostate Cancer

Other Conditions in Cleveland